Rapidly growing pharmaceutical services platform bolsters pricing and market access consulting arm with addition of channel strategy offering.
NASHVILLE, Tenn., Feb. 12, 2025 -- Petauri, a leading purpose-built pharmaceutical services platform, announced today the launch of its new channel strategy offering. This expanded service will be part of the organization's consulting arm, Petauri Advisors, which focuses on pricing, reimbursement, access, and value demonstration.
The Channel Strategy team will collaborate with emerging pharmaceutical manufacturers to define the optimal distribution path and flow for specific drugs, ensuring they reach patients and prescribers effectively. Additionally, this team will support established pharmaceutical companies by assessing their current network performance, developing new strategies for expanded therapeutic areas, and assisting with acquisitions and the integration of new networks.
To lead this team, Petauri has hired Kim Cline, an industry veteran with over 15 years of experience supporting commercialization strategy in nuanced drug launches. Cline's expertise in supporting life sciences start-ups with their drug distribution strategies, combined with her proven industry leadership, positions this team as a strong addition to Petauri's existing services. Adding this highly specialized area of focus allows the organization to deliver end-to-end solutions that address the full spectrum of challenges faced by pharmaceutical companies. "I am excited to build out this capability of the organization and look forward to bringing fresh ideas, flexible support, and a collaborative model to help pharma teams achieve success with their launches," said Cline.
"Our channel strategy practice is a natural extension for Petauri Advisors," said Steve O'Malley, President of Petauri Advisors. "We can better assist our clients with strategy and execution in their payer, pricing, and channel decisions. We are very fortunate to have Kim join our team. Her industry and consulting experience will help propel us forward."
About Petauri
Petauri is a purpose-built pharmaceutical services platform based in Nashville, Tennessee. Founded by CEO Dan Renick in partnership with Oak Hill Capital, the platform is launching, acquiring, and combining best-in-class companies with recognized expertise in global market access, medical affairs, commercialization support, patient services, and data and analytics. Since it was founded in 2023, the platform has launched Petauri Advisors and acquired The Kinetix Group, the agencies of FORCE Communications, Mtech Access, Delta Hat, the agencies of the Brightly Network, and Formulary Insights, all now Powered by Petauri™. Over time, Oak Hill will invest more than $250 million of equity capital in this initiative from its latest fund (OHCP VI). The platform works with pharmaceutical and life sciences clients to improve patient outcomes by establishing the scientific, economic, humanistic, and societal value of medical advances. From strategy to implementation, Petauri seamlessly supports these clients with a wide range of innovative solutions that speed patient access to life-changing care. For more information, please visit www.petauri.com.
This News is brought to you by Qube Mark, your trusted source for the latest updates and insights in marketing technology. Stay tuned for more groundbreaking innovations in the world of technology.
